Mutations in the PNPLA2 gene cause the onset of Neutral Lipid Storage Disease with Myopathy (NLSD-M), a rare autosomal recessive disorder characterized by an abnormal accumulation of triacylglycerol into cytoplasmic lipid droplets (LDs). PNPLA2 codes for adipose triglyceride lipase (ATGL), an enzyme that hydrolyses fatty acids from triacylglycerol. NLSD-M patients are mainly affected by progressive myopathy, cardiomyopathy and hepatomegaly. However, their clinical severity appears to be highly variable. Here we report the clinical and genetic findings of a NLSD-M Italian family with different affected members. In our patients we identified two novel PNPLA2 missense mutations (pL56R and pI193F). All three patients had Jordan's anomaly and lipid storage in cultured fibroblasts and in muscle biopsy. Molecular and functional analysis of PNPLA2 mutations is useful to explain the variation of clinical expression of this syndrome and it might improve prognosis. This is a very interesting family since it shows heterogeneity of clinical presentation from relatively asymptomatic phenotype to full expression of a severe myopathy.

Angelini, C., Tavian, D., Tasca, E., Missaglia, S., Familial distal myopathy due to PNPLA2 mutation, Abstract de <<American Academic of Neurology annual meeting 2014>>, (Philadelphia, 26-April 03-May 2014 ), N/A, Philadelphia 2014: 1-162 [http://hdl.handle.net/10807/65014]

Familial distal myopathy due to PNPLA2 mutation

Tavian, Daniela;Missaglia, Sara
2014

Abstract

Mutations in the PNPLA2 gene cause the onset of Neutral Lipid Storage Disease with Myopathy (NLSD-M), a rare autosomal recessive disorder characterized by an abnormal accumulation of triacylglycerol into cytoplasmic lipid droplets (LDs). PNPLA2 codes for adipose triglyceride lipase (ATGL), an enzyme that hydrolyses fatty acids from triacylglycerol. NLSD-M patients are mainly affected by progressive myopathy, cardiomyopathy and hepatomegaly. However, their clinical severity appears to be highly variable. Here we report the clinical and genetic findings of a NLSD-M Italian family with different affected members. In our patients we identified two novel PNPLA2 missense mutations (pL56R and pI193F). All three patients had Jordan's anomaly and lipid storage in cultured fibroblasts and in muscle biopsy. Molecular and functional analysis of PNPLA2 mutations is useful to explain the variation of clinical expression of this syndrome and it might improve prognosis. This is a very interesting family since it shows heterogeneity of clinical presentation from relatively asymptomatic phenotype to full expression of a severe myopathy.
Inglese
Scientific Abstract Listing and Annual Meeting Information AAN 2014
American Academic of Neurology annual meeting 2014
Philadelphia
26-apr-2014
3-mag-2014
N/A
Angelini, C., Tavian, D., Tasca, E., Missaglia, S., Familial distal myopathy due to PNPLA2 mutation, Abstract de <>, (Philadelphia, 26-April 03-May 2014 ), N/A, Philadelphia 2014: 1-162 [http://hdl.handle.net/10807/65014]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10807/65014
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact